Glinus lotoides linn. Seed extract as antidiabetic agent: In vitro and in vivo anti-glucolipotoxicity efficacy in Type-II diabetes mellitus
Background: Diabetes, especially type-II, prevailed despite recent medical advances. An edible G. lotoides (GL) seed is sold in Ethiopian traditional market such as ‘Merkato’ and used in folkloric medicine to treat diabetes. But to date not scientifically proven in this optic. As a result, this stud...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-06-01
|
| Series: | Metabolism Open |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589936822000275 |
| _version_ | 1818212806756925440 |
|---|---|
| author | Woretaw Sisay Yared Andargie Mulugeta Molla Getaye Tessema Pradeep Singh |
| author_facet | Woretaw Sisay Yared Andargie Mulugeta Molla Getaye Tessema Pradeep Singh |
| author_sort | Woretaw Sisay |
| collection | DOAJ |
| description | Background: Diabetes, especially type-II, prevailed despite recent medical advances. An edible G. lotoides (GL) seed is sold in Ethiopian traditional market such as ‘Merkato’ and used in folkloric medicine to treat diabetes. But to date not scientifically proven in this optic. As a result, this study set out to validate this claim. Methods: Following G. lotoides seed has been extracted, its antidiabetic efficacy was initially validated in vitro before in vivo investigation. The in vitro activity was probed by employing carbohydrate and lipid metabolizing enzymes inhibition assay. Based on this fact, the in vivo antidiabetic efficacy was conducted in normoglycemic, oral glucose-loaded and streptozotocin (150 mg/kg)-nicotinamide (65 mg/kg)-elicited type II diabetic rats. Results: The extract's LD50 was found to be greater than 2 g/kg. In vitro tests pill up evidence that seed extract foils carbohydrate and lipid metabolizing enzyme activities (p < 0.001). On the other hand, seed extract significantly abridged blood glucose in normoglycaemic rats markedly (p < 0.05–0.001). The highest dose exhibited the strongest glucose tolerance effect, with a maximum slaying (41.1%) in glucose-loaded rats' plasma glucose (p < 0.001). All doses of the extract ameliorate blood glucose levels significantly in diabetic rats after 4 weeks of therapy (p < 0.05–0.001). Likewise, all test doses tempered harmful lipides in diabetic rats markedly (p < 0.05–0.001). But HDL (p < 0.01–0.001) and body weight losses (p < 0.05–0.001) were rectified. Conclusion: In consequence, our data unveils the safety and glucolipotoxicity inhibition potential of G. lotoides seed extract, authenticating the traditional standpoint that it might be converted into a viable anti-diabetic lead upon subsequent investigations. |
| first_indexed | 2024-12-12T05:54:15Z |
| format | Article |
| id | doaj.art-a6a37308515f4c6d92a85f38463faa42 |
| institution | Directory Open Access Journal |
| issn | 2589-9368 |
| language | English |
| last_indexed | 2024-12-12T05:54:15Z |
| publishDate | 2022-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Metabolism Open |
| spelling | doaj.art-a6a37308515f4c6d92a85f38463faa422022-12-22T00:35:36ZengElsevierMetabolism Open2589-93682022-06-0114100189Glinus lotoides linn. Seed extract as antidiabetic agent: In vitro and in vivo anti-glucolipotoxicity efficacy in Type-II diabetes mellitusWoretaw Sisay0Yared Andargie1Mulugeta Molla2Getaye Tessema3Pradeep Singh4Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia; Corresponding author.Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaDepartment of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaDepartment of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaPharmaceutical Chemistry Unit, Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaBackground: Diabetes, especially type-II, prevailed despite recent medical advances. An edible G. lotoides (GL) seed is sold in Ethiopian traditional market such as ‘Merkato’ and used in folkloric medicine to treat diabetes. But to date not scientifically proven in this optic. As a result, this study set out to validate this claim. Methods: Following G. lotoides seed has been extracted, its antidiabetic efficacy was initially validated in vitro before in vivo investigation. The in vitro activity was probed by employing carbohydrate and lipid metabolizing enzymes inhibition assay. Based on this fact, the in vivo antidiabetic efficacy was conducted in normoglycemic, oral glucose-loaded and streptozotocin (150 mg/kg)-nicotinamide (65 mg/kg)-elicited type II diabetic rats. Results: The extract's LD50 was found to be greater than 2 g/kg. In vitro tests pill up evidence that seed extract foils carbohydrate and lipid metabolizing enzyme activities (p < 0.001). On the other hand, seed extract significantly abridged blood glucose in normoglycaemic rats markedly (p < 0.05–0.001). The highest dose exhibited the strongest glucose tolerance effect, with a maximum slaying (41.1%) in glucose-loaded rats' plasma glucose (p < 0.001). All doses of the extract ameliorate blood glucose levels significantly in diabetic rats after 4 weeks of therapy (p < 0.05–0.001). Likewise, all test doses tempered harmful lipides in diabetic rats markedly (p < 0.05–0.001). But HDL (p < 0.01–0.001) and body weight losses (p < 0.05–0.001) were rectified. Conclusion: In consequence, our data unveils the safety and glucolipotoxicity inhibition potential of G. lotoides seed extract, authenticating the traditional standpoint that it might be converted into a viable anti-diabetic lead upon subsequent investigations.http://www.sciencedirect.com/science/article/pii/S2589936822000275Glinus lotoidesAnti-hyperglycaemicDiabetes mellitusAnti-dyslipidaemiaStreptozotocin-nicotinamideα-amylase |
| spellingShingle | Woretaw Sisay Yared Andargie Mulugeta Molla Getaye Tessema Pradeep Singh Glinus lotoides linn. Seed extract as antidiabetic agent: In vitro and in vivo anti-glucolipotoxicity efficacy in Type-II diabetes mellitus Metabolism Open Glinus lotoides Anti-hyperglycaemic Diabetes mellitus Anti-dyslipidaemia Streptozotocin-nicotinamide α-amylase |
| title | Glinus lotoides linn. Seed extract as antidiabetic agent: In vitro and in vivo anti-glucolipotoxicity efficacy in Type-II diabetes mellitus |
| title_full | Glinus lotoides linn. Seed extract as antidiabetic agent: In vitro and in vivo anti-glucolipotoxicity efficacy in Type-II diabetes mellitus |
| title_fullStr | Glinus lotoides linn. Seed extract as antidiabetic agent: In vitro and in vivo anti-glucolipotoxicity efficacy in Type-II diabetes mellitus |
| title_full_unstemmed | Glinus lotoides linn. Seed extract as antidiabetic agent: In vitro and in vivo anti-glucolipotoxicity efficacy in Type-II diabetes mellitus |
| title_short | Glinus lotoides linn. Seed extract as antidiabetic agent: In vitro and in vivo anti-glucolipotoxicity efficacy in Type-II diabetes mellitus |
| title_sort | glinus lotoides linn seed extract as antidiabetic agent in vitro and in vivo anti glucolipotoxicity efficacy in type ii diabetes mellitus |
| topic | Glinus lotoides Anti-hyperglycaemic Diabetes mellitus Anti-dyslipidaemia Streptozotocin-nicotinamide α-amylase |
| url | http://www.sciencedirect.com/science/article/pii/S2589936822000275 |
| work_keys_str_mv | AT woretawsisay glinuslotoideslinnseedextractasantidiabeticagentinvitroandinvivoantiglucolipotoxicityefficacyintypeiidiabetesmellitus AT yaredandargie glinuslotoideslinnseedextractasantidiabeticagentinvitroandinvivoantiglucolipotoxicityefficacyintypeiidiabetesmellitus AT mulugetamolla glinuslotoideslinnseedextractasantidiabeticagentinvitroandinvivoantiglucolipotoxicityefficacyintypeiidiabetesmellitus AT getayetessema glinuslotoideslinnseedextractasantidiabeticagentinvitroandinvivoantiglucolipotoxicityefficacyintypeiidiabetesmellitus AT pradeepsingh glinuslotoideslinnseedextractasantidiabeticagentinvitroandinvivoantiglucolipotoxicityefficacyintypeiidiabetesmellitus |